Bio-Thera Moves Ahead With Secukinumab And Mepolizumab

Chinese Player’s Biosimilar Rivals To Cosentyx And Nucala Take Steps Forward

 
• By David Wallace
  
Clinical Trial Icon
Bio-Thera has revealed the latest details of its biosimilar trials • Source: Shutterstock

More from Biosimilars

More from Products